Beyond the Big Three PBMs - Managed Healthcare Executive
WEBDec 19, 2022 · But beyond the big three PBMs is a swarm of some 60 smaller, up-and-coming PBMs. Even if they are operating in a small slice of the pie relative to the towering dominance of the big three, the PBM pie is growing rapidly. The global PBM market is projected to increase from $495 billion in 2022 to $740 billion by 2029 (a 50% jump), according to a ...
How Capitation Contracts Benefit Providers, Payers and Patients
WEBMay 11, 2023 · Capitation contracts can benefit providers, payers, and patients. But they require thoughtful planning, careful alignment between PCPs and specialists, a commitment to optimizing the patient/member experience within a narrower network of providers, and a robust digital infrastructure. Lynn Carroll is the chief operating officer of HSBlox, an ...
Lilly Introduces Zepbound Single-Dose Vial for Cash-Paying Patients
WEBAug 27, 2024 · Article. The monthly price of the 2.5 mg Zepbound single-dose vial is $399 and the 5 mg dose is $549, which Lilly officials said is in line with the savings program for without insurance. Lilly has released a single-dose vial version of Zepbound (tirzepatide) for self-pay patients. The single-dose is available in 2.5 mg and 5 mg doses.
Patricia Weiser, Pharm.D. - Managed Healthcare Executive
WEBNew Study Highlights Impact of Obesity on Survival in Advanced NSCLC Patients Treated with Immunotherapy. Patricia Weiser, Pharm.D. August 13th 2024. Obesity is an important modifiable risk factor for developing cancer, second only to tobacco use. Obesity is traditionally defined as having a body mass index (BMI) of 30 kg/m2 or greater, while a ...
News - Managed Healthcare Executive
WEBFDA Accepts sNDA for Foam Psoriasis Drug Zoryve. Logan Lutton. September 24th 2024. The FDA has already approved Zoryve cream (0.3% and 0.15%) for plaque psoriasis and atopic dermatitis in adults and children ages 6 and up. Currently, Zoryve foam 0.3% is only approved to treat seborrheic dermatitis in adult and pediatric patients 9 years and older.
Five things to know about the role of GPOs in the healthcare …
WEBSep 14, 2017 · Based on our analysis, the following are 5 things to know about GPOs, their business model and role in the supply chain, and their impact on healthcare costs and competition: 1. GPOs source and negotiate prices for products and services. GPOs help source and negotiate prices for drugs, medical devices, and other products and services on …
More Patients Use and Trust Telehealth: Report
WEBFeb 20, 2022 · The report, released Feb. 16, showed substantial increases in patient comfort with telehealth in 2021, compared to 2020. Roughly 3 in 4 patients (73%) said they plan to use telemedicine after the pandemic, up from 58% in 2020. The study found 80% of patients with chronic illness would use telehealth beyond the pandemic, compared to …
PBMs are Creating GPOs, and Stirring Debate as to Why
WEBJul 12, 2022 · PBMs are Creating GPOs, and Stirring Debate as to Why. The Big Three all set up group purchasing organizations recently, but some industry observers question the timing of the move and who will benefit. In 2019, Express Scripts PBM (pharmacy benefit manager) formed Ascent Health Services GPO (group …
Thinking of “Carving Out” Specialty Benefits? Your Questions …
WEBJun 10, 2021 · CVS Health’s 2020 Drug Trend Report showed the outsized impact of specialty medications. Last year, 52% of money spent in the pharmacy benefit came from specialty medication even though only 2.5% of patients utilize them. Not surprisingly, many payers are looking at ways to reduce their specialty medication spend.
Top Three Reasons Why AI is Critical for Value-Based Care
WEBJun 27, 2023 · Reason 2: Equipping providers with valuable information at the point of care. Data and process fragmentation contributes to administrative complexity and costs the U.S. healthcare system more than $265 billion annually in unnecessary spending. Disjointed data across multiple records and a heavy reliance on retrospective claims data hinder ...